Outlook Therapeutics (OTLK) Revenue (2015 - 2026)
Outlook Therapeutics (OTLK) revenue from Mar 31, 2015 to Mar 31, 2026. The TTM Outlook Therapeutics (OTLK) revenue is $1.42M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Outlook Therapeutics (OTLK) Revenue CAGR table
| Period | CAGR |
|---|---|
| 10 Years TTM | -8.00% |
| All Time TTM | -8.00% |
Annual Revenue change of Outlook Therapeutics (OTLK)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $0 | -100.00% |
| 2025 | $1.41M | N/A |
| 2024 | $0 | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | -100.00% |
| 2019 | $8.15M | +163.75% |
| 2018 | $3.09M | -18.90% |
| 2017 | $3.81M | +27.85% |
| 2016 | $2.98M | -42.91% |
| 2015 | $5.22M | N/A |